Eyal Grunebaum Selected Research

Purine-Nucleoside Phosphorylase

11/2018	Intracellular Delivery of Human Purine Nucleoside Phosphorylase by Engineered Diphtheria Toxin Rescues Function in Target Cells.
5/2013	Purine nucleoside phosphorylase deficiency presenting as severe combined immune deficiency.
8/2012	Cerebellar abnormalities in purine nucleoside phosphorylase deficient mice.
7/2012	Defining combined immunodeficiency.
12/2008	Lentivirus gene therapy for purine nucleoside phosphorylase deficiency.
4/2006	Intracellular delivery of purine nucleoside phosphorylase (PNP) fused to protein transduction domain corrects PNP deficiency in vitro.
10/2004	Novel mutations and hot-spots in patients with purine nucleoside phosphorylase deficiency.
3/2004	Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eyal Grunebaum Research Topics

Disease

19	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021 - 03/2004
12	Purine Nucleoside Phosphorylase Deficiency 01/2022 - 03/2004
10	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2021 - 07/2007
7	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2017 - 02/2008
6	Infections 01/2018 - 10/2004
4	Hypersensitivity (Allergy) 01/2020 - 03/2004
3	Neoplasms (Cancer) 01/2022 - 06/2011
2	Anaphylaxis (Anaphylactic Shock) 09/2022 - 01/2022
2	Agammaglobulinemia (Hypogammaglobulinemia) 11/2021 - 01/2020
2	Lymphopenia (Lymphocytopenia) 01/2021 - 10/2004
2	Chronic Granulomatous Disease 01/2019 - 01/2017
2	Primary Immunodeficiency Diseases 01/2019 - 02/2008
2	Pulmonary Alveolar Proteinosis 05/2014 - 12/2013
2	Ataxia (Dyssynergia) 12/2013 - 03/2004
1	Colitis 11/2021
1	COVID-19 11/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Otitis Media 01/2021
1	Bacteremia 01/2021
1	Cytopenia 01/2020
1	Autoimmune Lymphoproliferative Syndrome 01/2019
1	Common Variable Immunodeficiency 01/2019
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2019
1	Epstein-Barr Virus Infections 01/2018
1	Nijmegen Breakage Syndrome 01/2018
1	Bone Marrow Failure Disorders 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Type 1 Hyper-IgM Immunodeficiency Syndrome 04/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Wiskott-Aldrich Syndrome 01/2017
1	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 01/2017
1	Metabolic Diseases (Metabolic Disease) 01/2016
1	Multiple Myeloma 01/2016
1	Body Weight (Weight, Body) 08/2015
1	Overweight 08/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 05/2013
1	ZAP70 deficiency 04/2013
1	DiGeorge Syndrome (Syndrome, DiGeorge) 10/2010
1	Measles 10/2010
1	Mumps 10/2010
1	Lung Diseases (Lung Disease) 10/2009
1	Liver Diseases (Liver Disease) 10/2009

Drug/Important Bio-Agent (IBA)

11	Adenosine DeaminaseIBA 01/2021 - 07/2007
10	EnzymesIBA 09/2022 - 03/2004
8	Purine-Nucleoside PhosphorylaseIBA 11/2018 - 03/2004
7	purineIBA 01/2021 - 12/2008
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2006
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2022 - 01/2021
2	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022 - 01/2021
2	trichostatin A (A 300)IBA 01/2022 - 01/2021
2	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022 - 01/2021
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2020 - 04/2009
2	Calcineurin InhibitorsIBA 01/2020 - 04/2009
2	CD40 Ligand (CD40L)IBA 01/2019 - 07/2012
2	DNA Ligase ATPIBA 01/2018 - 12/2008
2	Surface-Active Agents (Surfactants)IBA 12/2013 - 06/2012
2	SteroidsIBA 02/2011 - 02/2010
2	pegademase bovine (pegADA)FDA Link 10/2009 - 07/2007
2	Uric Acid (Urate)IBA 12/2008 - 10/2004
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 09/2022
1	Biomarkers (Surrogate Marker)IBA 09/2022
1	Platelet Activating FactorIBA 09/2022
1	fludarabineIBA 01/2022
1	pifithrinIBA 01/2022
1	LipopolysaccharidesIBA 11/2021
1	CTLA-4 AntigenIBA 11/2021
1	SARS-CoV-2 spike proteinIBA 11/2021
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2021
1	Methylcellulose (BFL)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	EpitopesIBA 01/2016
1	Busulfan (Busulfex)FDA Link 08/2015
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2013
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 05/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2013
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2012
1	Interleukin-10 ReceptorsIBA 07/2012
1	MitogensIBA 07/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2012
1	Periodic AcidIBA 06/2012
1	Hematoxylin (Haematoxylon)IBA 06/2012
1	CaspasesIBA 10/2011
1	Oxygen (Dioxygen)IBA 01/2011
1	Rubella VaccineIBA 10/2010
1	OsteoprotegerinIBA 10/2009
1	Analgesics (Analgesic Drugs)IBA 04/2009
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2009

Therapy/Procedure

7	Transplantation 01/2022 - 06/2012
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2011 - 02/2006
3	Hematopoietic Stem Cell Transplantation 10/2012 - 02/2008
2	Liver Transplantation 01/2020 - 01/2019
2	Cell Transplantation 04/2017 - 10/2012
2	Therapeutics 01/2011 - 04/2009
1	Organ Transplantation 01/2018
1	Stem Cell Transplantation 12/2013
1	Emergency Treatment 04/2013
1	Feeding Methods 10/2011